About NK-One Therapeutics
NK-One Therapeutics is a private company based in Wayne, Pennsylvania, incorporated in 2026 in Delaware. It has reported $290,000 raised in one offering on Form D since April 2026. Its chief executive is Michael Shine.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Apr 27, 2026 | $290,000of $310K target | 7 | $41,429 | Securities on exerciseRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NK-One Therapeutics's Form D filed Apr 27, 2026.
MP
MS